Underwriting AgreementUnderwriting Agreement • June 7th, 2024 • Becton Dickinson & Co • Surgical & medical instruments & apparatus
Becton, Dickinson and Company, a New Jersey corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”), for whom you (the “Representatives”) are acting as representatives, an aggregate of (i) $600,000,000 principal amount of its 5.081% Notes due 2029 (the “2029 Notes”).
BECTON DICKINSON EURO FINANCE S.À R.L. as Issuer BECTON, DICKINSON AND COMPANY as Guarantor AND THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee FIFTH SUPPLEMENTAL INDENTURE Dated as of June 7, 2024 4.029% Notes due 2036Fifth Supplemental Indenture • June 7th, 2024 • Becton Dickinson & Co • Surgical & medical instruments & apparatus • New York
FIFTH SUPPLEMENTAL INDENTURE (this “Supplemental Indenture”), dated as of June 7, 2024, among Becton Dickinson Euro Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 412 F route d’Esch, L-1471 Luxembourg and registered with the Luxembourg Trade and Companies Register under number B234229 (the “Company”), Becton, Dickinson and Company, a New Jersey corporation (the “Guarantor”), and The Bank of New York Mellon Trust Company, N.A., as trustee (the “Trustee”).
